Thursday, December 14, 2017 9:58:37 AM
While informative, and greatly appreciated, these are not really new news, and/or they are not the giant steps forward in revenue recognition, deal making, or KOL partnerships that are so sorely needed by AMBS.
Eltopra going back to trials will require funding. ESS was declared the 'low hanging fruit' before the financial abortion put AMBS shareholders in the poor house and we were slotted for US Army base burn victim test trial at 3 bases - and we are now only focusing on identifying new cGMP manufacturer?
I applaud AMBS capital restructuring efforts and attempt to regain its financial footing. Gerald aided by the help of Spence are attempting to uplist. While that too is a huge positive, I suspect it will come at a significant RS in order to attain the $2.00 or $3.00 pps for the NasDaq - plus all other financial requirements, updated financial filings and necessary cash on hand to fulfill that obligation. With 120-Mil. OS and 150-Mil. AS, were in tight quarters.
Will the 'uplisting from strength' of old which decimated the shareholder community and brought pain and suffering be the new spin to make those who have averaged down the kingpin for the new uplisting?
AJMHO
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM